"make a future together"
Pharmacological Evaluation Institute of Japan (PEIJ) is a non-profit pharmacology research institute. We are working with the activities globally for improvement in the reliability of the evaluation method of toxicity / safety and efficacy used in the case of drug development and chemical safety as an "ADAPTER". We are also working for STEAM education for all in the SDGs.
[2020.10.15-16, ICH]
A public webinar (ICH WG Presentations and Live Q&A) was held to provide an overview of the high-level principles and rationale behind the new interconnected Q&As to ICH E14 and S7B and to answer questions received during the webinar. ICH website.
[2020.08.27, ICH]
The ICH stage 1 Q&As are now available on the ICH website.
[2018.11, CiPA]
[2018.09.30-10.2, PEIJ]
PEIJ makes a poster presentation, "New Approach for Neuropharmacology Profile: In-Situ Real-Time Neuropharmacology Monitoring by Imaging Technique Using the Molecularly Imprinted Polymers (MIPs)", at Safety Pharmacology Society 2018 Annual Meeting.
[2018.04.27, CiPA]
Results from a Blinded CiPA Pailot Study
[2018.03.04, PEIJ]
PEIJ has an advanced science program for younger generation. We started a "PEIJ Youth Science Lab" and junior/senior high school students are joining us as PEIJ Junior Researchers. They are enjoying their own research activity including thesis reading/writing, discussion with richly experienced researchers, awareness survey, cell culture, etc. We encourage PEIJ Junior Researchers to think for themselves.
This roundtable discussion is presented by Ncardia and HESI and describes the current and evolving roles of human-induced pluripotent stem cell-derived cardiomyocytes and drug safety.
The ICH stage 1 Q&As are now available on the ICH website.